UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report

(Date of earliest event reported)

April 21, 2015

 

MARINUS PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36576

 

20-0198082

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

Three Radnor Corporate Center
100 Matsonford Road, Suite 304
Radnor, PA

 

19087

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (484) 801-4670

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On April 21, 2015, Marinus Pharmaceuticals, Inc. (the “Company”) held its 2015 Annual Meeting of Stockholders.  At the meeting, the stockholders voted on: (1) the election of two Class I directors and (2) the ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015.  The voting results on these proposals were as follows:

 

Proposal 1:  Election of Two Class I Directors

 

Director

 

Votes For

 

Withheld

 

Broker Non-votes

 

Christopher M. Cashman

 

7,797,907

 

329,787

 

1,484,513

 

 

 

 

 

 

 

 

 

Stephen Bloch, M.D.

 

7,797,907

 

329,787

 

1,484,513

 

 

Proposal 2:  Ratification of the appointment of KPMG LLP as the Company’s independent registered public accountant firm for the year ending December 31, 2015

 

Votes For

 

Votes Against

 

Abstentions

 

9,487,645

 

124,562

 

0

 

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MARINUS PHARMACEUTICALS, INC.

 

 

 

 

 

 

 

 

By:

/s/ Edward Smith

 

 

 

Edward Smith,

 

 

 

Vice President, Chief Financial Officer,

 

 

 

Secretary and Treasurer

 

Date:  April 23, 2015

 

3